Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

about

Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia Tenascin-X is a novel diagnostic marker of malignant mesothelioma Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1 Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase Identification of reference genes across physiological states for qRT-PCR through microarray meta-analysis Dynamics of resistance development to imatinib under increasing selection pressure: a combination of mathematical models and in vitro data HEX expression and localization in normal mammary gland and breast carcinoma CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation NPM1 deletion is associated with gross chromosomal rearrangements in leukemia Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Quantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues.Comparison of the latest commercial short and long oligonucleotide microarray technologies.Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer.Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α.Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.RNA quantification using gold nanoprobes - application to cancer diagnostics CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells.Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury.Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Chronic Myelogenous Leukemia, Version 1.2014 Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

P2860

Q24599447-C3D9A09A-DAC2-4A42-B7F0-B89DDC48950E Q24604850-4A2C29EA-196C-49EB-B9C6-270933AE1B3C Q24649948-70816307-E90B-4A1D-A874-34D3757723BB Q26828511-0136378E-A8FC-4AF5-A545-F00FDEAC83B8 Q28283017-156880F5-5538-4C32-9499-5C6E954B47B5 Q28290118-293F10BB-BB22-4D59-95F3-7F1CD6C85CD2 Q28297413-047105CE-C1E5-4780-8589-8BCE3E403BCB Q28386490-EDEB4670-F978-4697-B4D1-711DB1864F9A Q28478542-46BC6EE9-0EC5-4856-B01B-45B766F56681 Q28504757-3CFE6121-EE29-4985-A1B7-C78DE60906CB Q28543785-CCAC1091-66DB-446E-B792-C5D5939313F7 Q28552969-857DF6B0-D8D9-4F07-85C5-CA47FFBB72F1 Q28749228-2F4BC313-4BDE-4078-9AEF-64863DE4838A Q29614510-9547F195-80B2-4AD3-AAF3-33CF69D5C143 Q30492706-B03F57BC-1907-4798-874D-84007C3DF3DE Q33236641-0FB62EC0-CD49-48A1-AA2C-B81397DF0329 Q33307453-D311D488-4A87-4F3A-9D68-9A317AA043E5 Q33555627-51A05DBB-1833-4FB3-8233-E2F1153518BA Q33587563-CB9DFC1A-5FED-43AA-B028-18FF7742B061 Q33587624-6C5D1BE8-8EFA-4A81-8A7A-B48529AA6054 Q33597549-A8EC6D55-E66B-40DA-9EB3-795993305064 Q33659118-BC2B9C68-5628-4694-90EC-8031AB2D67A2 Q33748792-9FFF57F5-0DB2-4060-B844-477FD3256A78 Q33755327-DA284153-48CE-47E7-9D7F-42F063D7681E Q33765598-775BC979-4853-4038-83A4-976F5F123807 Q33781178-F92B0427-05BC-44E4-A9B3-4635077EEB11 Q33798318-689D5A2D-2287-46F8-8822-65DEA7A52AB0 Q33822032-D5941B27-6153-4B3A-B6AE-010DF43B5B76 Q33829079-37597ED5-CA42-4B6B-886D-51CCD66D434D Q33829373-97CC1C55-5FE4-4E6B-8CEC-BDBE9B37EEED Q33862467-D0C5F0CB-37F0-4810-9DF4-A3450C522ED7 Q33873297-20B245FD-CA18-45CC-AEAD-7500E3F9E1DC Q33886181-B5D1257C-456C-4E87-BA4E-A02BBB230857 Q33899947-A6686303-0923-4A41-B89D-FA042E012270 Q33956085-F348CA44-D4B7-4A3B-8472-B05F8B3D5481 Q34155213-CFEA8DD2-3FE1-441C-9540-EC85085AF996 Q34340727-E028D025-A6BD-4682-8611-4E0088829CAC Q34427193-0D7896D5-B6C8-4545-9F1A-C6D1359674A4 Q34522810-675A1FA3-B84C-40E8-9DAE-556189B108F4 Q34561626-EDF91CF5-9502-4D64-B345-DA0BDB9F794A

P2860

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Item

http://www.wikidata.org/entity/Q31012437

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu